FIELD: medicine, microbiology. SUBSTANCE: invention relates to a medicinal preparation prepared from the strain Staphylococcus aureus C2 GISK N 222 after preliminary the development stage. An agent shows biological activity 19%, not less, by an index of elimination of an inflammatory response containing protein in concentration 0.0063-0.063 mg/ml in an inhalation form and providing a size of inhaling particles 2-5 mcm that ensures to treat diseases affecting low respiratory ways bronchi, bronchioles, alveoles, in part, bronchial asthma. The preparation has a low protein load on patient and in distinction with other similar preparations has nonhormonal origin. EFFECT: enhanced effectiveness of agent, valuable medicinal properties. 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIALLERGIC, ANTIINFLAMMATORY AGENT, METHOD OF ITS PREPARING, CURATIVE AND COSMETIC AGENT AND ITS USE | 1996 |
|
RU2098109C1 |
CONCENTRATE FOR PREPARING ANTI-ALLERGIC ANTI-INFLAMMATORY AGENT | 2001 |
|
RU2192874C1 |
METHOD FOR TREATING BRONCHIAL ASTHMA IN CHILDREN IN ATTACK PERIOD | 2002 |
|
RU2236219C2 |
METHOD OF DETERMINING MYOCARDIAL DEFFICIENCY IN CHRONIC BRONCHOPULMONARY PATIENTS | 0 |
|
SU1388808A1 |
METHOD TO TREAT BRONCHIAL ASTHMA | 1995 |
|
RU2108121C1 |
METHOD FOR TREATING THE CASES OF BRONCHIAL ASTHMA | 1995 |
|
RU2108817C1 |
BRONCHIAL ASTHMA TREATMENT MODE | 2008 |
|
RU2360698C1 |
METHOD FOR PREVENTING EXACERBATIONS OF BRONCHIAL ASTHMA | 2003 |
|
RU2252785C1 |
METHOD OF TREATMENT OF STEROID-DEPENDENT BRONCHIAL ASTHMA | 2007 |
|
RU2348431C1 |
METHOD FOR BRONCHIAL ASTHMA TREATMENT | 2015 |
|
RU2626768C2 |
Authors
Dates
2002-10-20—Published
2001-08-14—Filed